Pharmacological Modulation of Dopamine Receptor D2-Mediated Transmission Alters the Metabolic Phenotype of Diet Induced Obese and Diet Resistant C57Bl6 Mice
Figure 1
Bodyweight (a) and fat mass (b) of DIO and DR mice after treatment with bromocriptine (BC), haloperidol (HP), or placebo (P) for 2 weeks. Data is presented as mean ± SD for 12 (a) or 10 (b) mice per group. **; ***.
